Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,729
Closed -$3.45M 424
2024
Q4
$3.45M Buy
+20,729
New +$3.68M 0.09% 112
2024
Q2
Sell
-52,486
Closed -$6.59M 614
2024
Q1
$6.59M Buy
52,486
+40,560
+340% +$4.64M 0.19% 68
2023
Q4
$1.26M Buy
11,926
+7,000
+142% +$764K 0.04% 243
2023
Q3
$522K Buy
4,926
+2,933
+147% +$339K 0.01% 399
2023
Q2
$237K Buy
+1,993
New +$206K 0.01% 476
2018
Q2
Sell
-117,642
Closed -$5.38M 337
2018
Q1
$5.38M Buy
117,642
+82,944
+239% +$4.12M 0.1% 99
2017
Q4
$1.64M Sell
34,698
-305,409
-90% -$15M 0.03% 218
2017
Q3
$16.4M Buy
+340,107
New +$16.9M 0.24% 88
2017
Q2
Sell
-175,000
Closed -$7.81M 453
2017
Q1
$7.81M Buy
+175,000
New +$7.29M 0.13% 162
2016
Q3
Sell
-368,099
Closed -$15.1M 475
2016
Q2
$15.1M Buy
368,099
+188,099
+104% +$7.51M 0.32% 83
2016
Q1
$7.36M Buy
+180,000
New +$6.66M 0.14% 165
2015
Q3
Sell
-75,000
Closed -$3.02M 668
2015
Q2
$3.02M Sell
75,000
-197,429
-72% -$8.56M 0.05% 294
2015
Q1
$11.8M Buy
+272,429
New +$11.8M 0.25% 122

Other funds holding ORCL

UBS O'Connor's ORCL Position: Q1 2025 in Review

UBS O'Connor sold out of Oracle (ORCL) in Q1 2025, closing a stake of 20,729 shares — an estimated $3.45M sold.

UBS O'Connor first reported a position in ORCL in Q1 2015 and held it in 13 quarters. The position peaked at $16.4M in Q3 2017. 3,245 funds tracked by Wall St. Rank hold ORCL as of Q1 2025.

  • UBS O'Connor reported no remaining Oracle position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 20,729 Oracle shares in Q1 2025, an estimated $3.45M.
  • UBS O'Connor first reported a position in Oracle in Q1 2015 and held it in 13 quarters.
  • UBS O'Connor's Oracle position peaked at $16.4M in Q3 2017.
  • 3,245 funds tracked by Wall St. Rank held Oracle as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.